These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 19879831)

  • 1. Tetherin is as tetherin does.
    Hammonds J; Spearman P
    Cell; 2009 Oct; 139(3):456-7. PubMed ID: 19879831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetherin inhibits HIV-1 release by directly tethering virions to cells.
    Perez-Caballero D; Zang T; Ebrahimi A; McNatt MW; Gregory DA; Johnson MC; Bieniasz PD
    Cell; 2009 Oct; 139(3):499-511. PubMed ID: 19879838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane.
    Hammonds J; Wang JJ; Yi H; Spearman P
    PLoS Pathog; 2010 Feb; 6(2):e1000749. PubMed ID: 20140192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.
    Strauss JD; Hammonds JE; Yi H; Ding L; Spearman P; Wright ER
    J Virol; 2016 Feb; 90(3):1507-21. PubMed ID: 26582000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.
    Lehmann M; Rocha S; Mangeat B; Blanchet F; Uji-I H; Hofkens J; Piguet V
    PLoS Pathog; 2011 Dec; 7(12):e1002456. PubMed ID: 22194693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Lassa and Marburg virus production by tetherin.
    Sakuma T; Noda T; Urata S; Kawaoka Y; Yasuda J
    J Virol; 2009 Mar; 83(5):2382-5. PubMed ID: 19091864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How innate immunity can inhibit the release of HIV-1 from infected cells.
    Guatelli J
    N Engl J Med; 2010 Feb; 362(6):553-4. PubMed ID: 20147723
    [No Abstract]   [Full Text] [Related]  

  • 9. Tetherin restricts productive HIV-1 cell-to-cell transmission.
    Casartelli N; Sourisseau M; Feldmann J; Guivel-Benhassine F; Mallet A; Marcelin AG; Guatelli J; Schwartz O
    PLoS Pathog; 2010 Jun; 6(6):e1000955. PubMed ID: 20585562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes.
    Iwabu Y; Fujita H; Kinomoto M; Kaneko K; Ishizaka Y; Tanaka Y; Sata T; Tokunaga K
    J Biol Chem; 2009 Dec; 284(50):35060-72. PubMed ID: 19837671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCA2/Rabring7 promotes tetherin-dependent HIV-1 restriction.
    Miyakawa K; Ryo A; Murakami T; Ohba K; Yamaoka S; Fukuda M; Guatelli J; Yamamoto N
    PLoS Pathog; 2009 Dec; 5(12):e1000700. PubMed ID: 20019814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
    Blondeau C; Pelchen-Matthews A; Mlcochova P; Marsh M; Milne RS; Towers GJ
    J Virol; 2013 Dec; 87(24):13124-33. PubMed ID: 24067975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The great escape: viral strategies to counter BST-2/tetherin.
    Douglas JL; Gustin JK; Viswanathan K; Mansouri M; Moses AV; Früh K
    PLoS Pathog; 2010 May; 6(5):e1000913. PubMed ID: 20485522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
    Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.
    Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V
    PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.
    Ali MS; Hammonds J; Ding L; Spearman P
    PLoS One; 2010 Feb; 5(2):e9005. PubMed ID: 20126395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
    Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
    J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
    Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
    Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
    Heusinger E; Kluge SF; Kirchhoff F; Sauter D
    J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BST-2 diminishes HIV-1 infectivity.
    Zhang J; Liang C
    J Virol; 2010 Dec; 84(23):12336-43. PubMed ID: 20861258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.